Optimizing the potential of antibody-drug conjugates in oncology

被引:1
|
作者
Mosele, F. [1 ,2 ]
Montagnac, G. [3 ]
Pistilli, B. [1 ]
Andre, F. [1 ,2 ,4 ]
机构
[1] Gustave Roussy, Dept Med Oncol, Villejuif, France
[2] Gustave Roussy, INSERM, U981, Villejuif, France
[3] Gustave Roussy, INSERM, U1279, Villejuif, France
[4] Univ Paris Saclay, Fac Med, Le Kremlin Bicetre, France
关键词
RESISTANT OVARIAN-CANCER; MIRVETUXIMAB SORAVTANSINE; SACITUZUMAB GOVITECAN; PHASE-III; CHEMOTHERAPY; DERUXTECAN;
D O I
10.1016/j.annonc.2023.08.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:964 / 967
页数:4
相关论文
共 50 条
  • [21] Potential of antibody-drug conjugates (ADCs) for cancer therapy
    Marei, Hany E.
    Cenciarelli, Carlo
    Hasan, Anwarul
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [22] Monoclonal antibody-drug conjugates
    Hamann, PR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (09) : 1087 - 1103
  • [23] Enthusiasm for Antibody-Drug Conjugates
    Tuma, Rabiya S.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (20) : 1493 - 1494
  • [24] Antibody-Drug Conjugates for Immunology
    Dragovich, Peter S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (06) : 4496 - 4499
  • [25] BUILDING ANTIBODY-DRUG CONJUGATES
    Thayer, Ann M.
    CHEMICAL & ENGINEERING NEWS, 2014, 92 (03) : 13 - +
  • [26] RETHINKING ANTIBODY-DRUG CONJUGATES
    Jarvis, Lisa M.
    CHEMICAL & ENGINEERING NEWS, 2012, 90 (25) : 12 - +
  • [27] Introduction to Antibody-Drug Conjugates
    Pettinato, Mark C.
    ANTIBODIES, 2021, 10 (04)
  • [28] The Promise of Antibody-Drug Conjugates
    Teicher, Beverly A.
    Doroshow, James H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19): : 1847 - 1848
  • [29] Antibody-drug conjugates for cancer
    Chau, Cindy H.
    Steeg, Patricia S.
    Figg, William D.
    LANCET, 2019, 394 (10200): : 793 - 804
  • [30] Payloads for Antibody-Drug Conjugates
    Goundry, William R. F.
    Parker, Jeremy S.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2022, 26 (08) : 2121 - 2123